Barclays PLC Elanco Animal Health Inc Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Barclays PLC holds 729,294 shares of ELAN stock, worth $15.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
729,294
Previous 557,788
30.75%
Holding current value
$15.4 Million
Previous $7.96 Million
84.42%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ELAN
# of Institutions
464Shares Held
492MCall Options Held
780KPut Options Held
1.08M-
Dodge & Cox San Francisco, CA82.8MShares$1.75 Billion0.96% of portfolio
-
Primecap Management CO Pasadena, CA50MShares$1.05 Billion0.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.6MShares$1.02 Billion0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD31.5MShares$665 Million0.39% of portfolio
-
Dimensional Fund Advisors LP Austin, TX24.7MShares$521 Million0.11% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...